Quantessence Capital’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-51,243
Closed -$131K 379
2025
Q1
$131K Buy
+51,243
New +$131K 0.03% 296